Cargando…

Before and After: Attitude and Adverse Effects Induced by the First and Second Doses of mRNA BNT162b2 Vaccine among Healthcare Professionals in the First Weeks after Their Introduction in Poland

Background: In the last days of December 2020, the SARS-CoV-2 virus vaccine BNT162b2 (Comirnaty, Pfizer-BioNTech) was introduced, for the first time, for wide use in Poland. According to the vaccination schedule, healthcare workers were the first to receive the vaccine. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasternak, Gerard, Pieniawska-Śmiech, Karolina, Walkowiak, Mateusz, Sado, Joanna, Pytel, Adam, Jasińska, Paulina, Kierbiedź-Guzik, Natalia, Bolaczek, Paula, Fleischer-Stępniewska, Katarzyna, Babicki, Mateusz, Pentoś, Katarzyna, Lewandowicz-Uszyńska, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222834/ https://www.ncbi.nlm.nih.gov/pubmed/37242987 http://dx.doi.org/10.3390/vaccines11050883

Ejemplares similares

Assessment of weight and height of patients with primary immunodeficiency disorders and group of children with recurrent respiratory tract infections
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2020)

Analysis of differences between total IgG and sum of the IgG subclasses in children with suspected immunodeficiency – indication of determinants
por: Pasternak, Gerard, et al.
Publicado: (2018)

Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2021)

Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2022)

Serum Allergen-Specific IgE among Pediatric Patients with Primary Immunodeficiency
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2022)

Assessment of autoantibodies in paediatric population with primary immunodeficiencies: a pilot study
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2023)

Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)—Report of two cases and literature review
por: Biela, Mateusz, et al.
Publicado: (2021)

Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up
por: Babicki, Mateusz, et al.
Publicado: (2023)

Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccine
por: Wu, Bryan, et al.
Publicado: (2022)

Giant cell myocarditis after first dose of BNT162b2 – a case report
por: Hirsch, Valentin G., et al.
Publicado: (2022)

Attitudes toward Vaccination against COVID-19 in Poland. A Longitudinal Study Performed before and Two Months after the Commencement of the Population Vaccination Programme in Poland
por: Babicki, Mateusz, et al.
Publicado: (2021)

The Potential Role of Serum and Exhaled Breath Condensate miRNAs in Diagnosis and Predicting Exacerbations in Pediatric Asthma
por: Kierbiedź-Guzik, Natalia, et al.
Publicado: (2023)

miRNAs as Modern Biomarkers in Asthma Therapy
por: Kierbiedź-Guzik, Natalia, et al.
Publicado: (2023)

Alterations in mental health and quality of life among healthcare workers in times of COVID-19: Four-stage cross-sectional study during first four pandemic waves in Poland
por: Babicki, Mateusz, et al.
Publicado: (2022)

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report
por: Mücke, Victoria Therese, et al.
Publicado: (2021)

Will Bivalent Vaccination against COVID-19 Increase the Desire for COVID-19 Vaccination among Poles?
por: Babicki, Mateusz
Publicado: (2022)

Use of Alcohol, Cannabinoids, Psychostimulants, and Sedatives before and during the COVID-19 Pandemic among Students in 40 European Countries
por: Babicki, Mateusz
Publicado: (2022)

Comparison of VOC Emissions Produced by Different Types of Adhesives Based on Test Chambers
por: Kozicki, Mateusz, et al.
Publicado: (2021)

BNT162b2 mRNA COVID-19 Vaccine: First Approval
por: Lamb, Yvette N.
Publicado: (2021)

Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI
por: Pellini, Raul, et al.
Publicado: (2021)

Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
por: Ruhe, Johannes, et al.
Publicado: (2021)

A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine
por: Yamamoto, Kana, et al.
Publicado: (2021)

Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents
por: Tuaillon, Edouard, et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study
por: Kang, Yu Min, et al.
Publicado: (2021)

Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Allergic reaction to anisakis-contaminated fish after the first administration of BNT162b2 mRNA vaccine: a case report
por: Harada, Fumiue, et al.
Publicado: (2022)

Role of Histone Deacetylases in T-Cell Development and Function
por: Pieniawska, Monika, et al.
Publicado: (2022)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Acute interstitial nephritis after vaccination with BNT162b2
por: Rieckmann, Sonja, et al.
Publicado: (2022)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine
por: Gobbi, Federico, et al.
Publicado: (2021)

Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine
por: Raw, Rachael K., et al.
Publicado: (2022)

Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses
por: Braun, Eyal, et al.
Publicado: (2022)

The first reported case of G6PD deficiency due to Seoul mutation in Poland
por: Kaczorowska-Hac, Barbara, et al.
Publicado: (2013)

Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland
por: Babicki, Mateusz, et al.
Publicado: (2022)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
por: Bauernfeind, Stilla, et al.
Publicado: (2021)

Decline of immune humoral response after BNT162b2 vaccine
por: Ferri, Sonia, et al.
Publicado: (2022)

Aseptic meningitis after BNT-162b2 COVID-19 vaccination
por: Chan, Amanda CY., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i38cfrd6l3jtp9du9ntdij4ghg